Amarin (AMRN) P/S (1999 - 2026)
Amarin (AMRN) P/S from Nov 1, 1999 to Jul 21, 2026. The TTM Amarin (AMRN) P/S is 1.35. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Amarin (AMRN)
| Year | P/S | Change |
|---|---|---|
| 2026 | 1.35 | -0.81% |
| 2025 | 1.36 | +55.68% |
| 2024 | 0.87 | -20.79% |
| 2023 | 1.10 | -4.48% |
| 2022 | 1.15 | -49.65% |
| 2021 | 2.29 | -26.69% |
| 2020 | 3.13 | -82.60% |
| 2019 | 17.96 | -7.15% |
| 2018 | 19.35 | +195.58% |
| 2017 | 6.55 | -6.83% |
| 2016 | 7.03 | +231.38% |
| 2015 | 2.12 | +34.38% |
| 2014 | 1.58 | -75.56% |
| 2013 | 6.45 | +50.20% |
| 2010 | 4.30 | +55.26% |
| 2009 | 2.77 | +101.39% |
| 2008 | 1.37 | -72.69% |
| 2007 | 5.03 | -88.60% |
| 2006 | 44.14 | +90.00% |
| 2005 | 23.23 | -55.72% |
| 2004 | 52.46 | +75.97% |
| 2003 | 29.81 | -61.40% |
| 2002 | 77.24 | -77.03% |
| 2001 | 336.24 | +215.82% |
| 2000 | 106.47 | +15.79% |
| 1999 | 91.95 | N/A |
Comparison Amarin (AMRN) P/S with competitors
Amarin (AMRN) P/S is 1.35.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -57.35% |
| NVO | Novo Nordisk | 0.66 | -50.90% |
| GRFS | Grifols SA | 0.67 | -50.23% |
| SCLX | Scilex Holding Company | 1.92 | +42.04% |
| SNY | Sanofi | 2.18 | +61.91% |
| PFE | Pfizer Inc | 2.18 | +61.91% |
| BMY | Bristol-Myers Squibb Company | 2.40 | +77.93% |
| BIIB | Biogen Inc | 2.93 | +117.32% |
| GSK | GSK Plc | 3.22 | +139.12% |
| MRK | Merck & Co Inc | 4.54 | +236.44% |
| AZN | Astrazeneca plc | 4.58 | +240.07% |
| NVS | Novartis AG | 5.07 | +276.04% |
| AMGN | AMGEN Inc | 5.15 | +281.98% |
| GILD | Gilead Sciences Inc | 5.43 | +302.74% |
| JNJ | Johnson & Johnson | 6.34 | +370.24% |
| ABBV | Abbvie Inc | 7.15 | +430.32% |
| LLY | Lilly(Eli) & Company | 14.28 | +959.15% |